Merck Pre-Tax Income 2010-2024 | MRK

Merck pre-tax income for the twelve months ending June 30, 2024 was $15.250B, a 181.83% increase year-over-year.

  • Merck annual pre-tax income for 2023 was $1.889B, a 88.51% decline from 2022.
  • Merck annual pre-tax income for 2022 was $16.444B, a 18.48% increase from 2021.
  • Merck annual pre-tax income for 2021 was $13.879B, a 136.72% increase from 2020.

Merck Pre-Tax Income 2010-2024 | MRK

  • Merck annual pre-tax income for 2023 was $1.889B, a 88.51% decline from 2022.
  • Merck annual pre-tax income for 2022 was $16.444B, a 18.48% increase from 2021.
  • Merck annual pre-tax income for 2021 was $13.879B, a 136.72% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$495.1B
Johnson & Johnson (JNJ)$450.1B
Novo Nordisk (NVO)$424.5B
AbbVie (ABBV)$264.1B
AstraZeneca (AZN)$218.5B
Novartis AG (NVS)$218.4B
Pfizer (PFE)$201.2B
Sanofi (SNY)$133B
Innoviva (INVA)$953M